BOSTON, Feb. 27, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo, will be presenting at the Cowen & Company 34th Annual Health Care Conference at The Boston Marriott Copley Place, in Boston. The Company will present at 9:20 a.m. EST on Wednesday, March 5, 2014.
Investors unable to attend the Cowen & Co. Conference may listen in to the webcast, which can be found on the Investors section of the Company's website at www.inspire-md.com/site_en/for-investors/. The webcast will be available for 90 days following the presentation.
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MGuard™ with MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.
InspireMD intends to pursue applications of this MicroNet technology in coronary, carotid (CGuard™) and peripheral artery procedures. InspireMD's common stock is quoted on the NYSE MKT under the ticker symbol NSPR.
SOURCE InspireMD, Inc.